Quantcast
Last updated on April 19, 2014 at 18:42 EDT

Latest Sigma-Aldrich Stories

2013-12-03 08:31:39

ST. LOUIS, Dec. 3, 2013 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced its Supelco(®) brand has released Titan UHPLC columns manufactured using the Company's new cost-efficient, patent-pending Ecoporous(TM) silica manufacturing process. Starting at a list price of $300, Titan columns contain the first sub-2 micrometer porous silica that is monodisperse and high-performance (>250,000 plates per meter), combining the advantages of solid-core and...

2013-12-02 23:03:15

Reportbuyer.com just published a new market research report: Enhancing the Customer Experience: Insights and Life Science Supplier Rankings. London (PRWEB) December 02, 2013 Study Objectives: •Provide vendors with the ability to benchmark the customer experience enjoyed by their customers against those of competitors. •Identify the relative strengths and weaknesses of each vendor on each customer experience touchpoint. •Determine the relative importance of each touchpoint in the...

2013-12-02 08:24:13

DUBLIN, December 2, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/64fm65/global_chiral) has announced the addition of the "Global Chiral Technology Market 2012-2016" [http://www.researchandmarkets.com/research/64fm65/global_chiral ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) One of the key factors contributing to this market growth is favorable government regulations for chiral...

2013-11-25 16:27:15

RICHMOND, Calif., Nov. 25, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic(® )development programs and an overview of the company's business strategy at 8:00 am ET on Wednesday, December 4, 2013, at the 25th Annual Piper Jaffray Healthcare Conference, which will be held in New York City. (Logo:...

2013-11-14 16:25:32

DUBLIN, November 14, 2013 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/ftn84k/proteomics ) has announced the addition of the "Proteomics - Global Strategic Business Report" [http://www.researchandmarkets.com/research/ftn84k/proteomics ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report analyzes the worldwide markets for Proteomics...

2013-11-13 12:27:32

DUBLIN, Ireland, November 13, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/gdzsbp/global_biobank) has announced the addition of the "Global Biobank (Biospecimen/Biorepository/Biopreservation) Market For Equipment & Media - Trends & Forecast to 2017" [http://www.researchandmarkets.com/research/gdzsbp/global_biobank ] report to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769...

2013-11-05 08:33:33

ST. LOUIS, Nov. 5, 2013 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that SAFC(®) Commercial (www.sigma-aldrich.com/safc), its custom manufacturing services business unit, has entered into a services agreement with CatScI Ltd. (www.catsci.com), a UK-based catalysis company focused on maximizing yield, optimizing quality, reducing waste and minimizing chemical development costs through reaction understanding. SAFC customers will immediately benefit from the...

2013-11-01 08:25:12

DUBLIN, November 1, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/p37ckx/proteomics_market) has announced the addition of the "Proteomics Market (Protein Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, Protein Fractionation, X-ray Crystallography, Immunoassay) - Instruments, Reagents and Services - Trends and Globa"...

2013-10-23 16:30:15

Recent Financing Enhances Cash Position RICHMOND, Calif., Oct. 23, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today reported third quarter 2013 financial results and accomplishments. (Logo: http://photos.prnewswire.com/prnh/20130102/SF35903LOGO) For the third quarter ended September 30, 2013, Sangamo reported a consolidated net loss of $6.1 million, or $0.11 per share, compared to a net loss of $5.8 million, or $0.11 per share, for the same period in 2012. As of September...

2013-10-22 08:31:59

ST. LOUIS, Oct. 22, 2013 /PRNewswire/ -- HIGHLIGHTS: Q3 2013 Results (all percentages are to comparable periods in 2012) -- Q3 2013 reported sales increased 4% to $664 million, and overall organic sales growth was 5%. By business unit, organic sales growth was 3% for Research, 4% for Applied and 8% for SAFC Commercial. Changes in foreign currency exchange rates reduced otherwise reportable overall sales by 1%. -- Q3 2013 reported diluted EPS was...